China Pharmaceutical University
Records under this name other than the patents China Pharmaceutical University holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 23 patents it holds.
Back to China Pharmaceutical University
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,664,238 | Indenoisoquinolinone derivatives, manufacturing method and medical use thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,846,752 | Isoflavone fatty acid ester derivatives, preparation method and pharmaceutical uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,442,759 | 1-sulfonamido-4-aryloxy compounds, and preparation method and medicinal application thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,028,073 | Butylphthalide-telmisartan hybrids, preparation method and application thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,814,352 | Salts formed by 2-(1-acyloxy-n-pentyl) benzoic acid and basic amino acid or aminoguanidine, and preparation method and application thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,859,527 | Inclusion Complex of Deoxypodophyllotoxin of Cyclodextrin, Preparation Method, Use for Treatment of Cancer Thereof Lapsed on the fee record Ended Oct 14, 2026 · High confidence | Lapsed on the fee record | Ended Oct 14, 2026 | High confidence |
| US 8,802,824 | Modified Recombinant Human Endostatin and Uses Thereof Formerly held Lapsed on the fee record Ended Aug 12, 2026 · High confidence | Lapsed on the fee record | Ended Aug 12, 2026 | High confidence |
| US 11,304,926 | Application of transient receptor potential cation channel TRPV3 in developing drug for preventing or treating psoriasis Lapsed on the fee record Ended Apr 19, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 19, 2026 | USPTO record |
| US 9,943,524 | Use of alkaloid in preparing pharmaceutical compositions for preventing or treating pulmonary fibrosis Lapsed on the fee record Ended Apr 17, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 17, 2026 | USPTO record |
| US 11,242,340 | Crystal forms of demethyleneberberine hydrochloride and preparation method therefor Lapsed on the fee record Ended Feb 8, 2026 · USPTO record | Lapsed on the fee record | Ended Feb 8, 2026 | USPTO record |